Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PNU-159682 is a highly effective metabolite of the anthracycline nemorubicin. PNU-159682 has outstanding cytotoxicity. PNU-159682 is an effective ADCs cytotoxin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 84.00 | |
5 mg | In stock | $ 198.00 | |
10 mg | In stock | $ 363.00 | |
25 mg | In stock | $ 767.00 | |
50 mg | In stock | $ 1,180.00 | |
100 mg | In stock | $ 1,830.00 |
Description | PNU-159682 is a highly effective metabolite of the anthracycline nemorubicin. PNU-159682 has outstanding cytotoxicity. PNU-159682 is an effective ADCs cytotoxin. |
Targets&IC50 | CA IX:25 nM, Topo II unknotting activity:100 μM |
In vitro | PNU-159682 inhibits a panel of human tumor cell lines (IC70 values in the range of 0.07-0.58 nM). PNU-159682 is 2,360- to 790-fold and 6,420- to 2,100-fold more potent than MMDX and doxorubicin, respectively. PNU-159682 displays cytotoxic effect on CAIX-expressing SKRC-52 cells (IC50: 25 nM). PNU-159682 (10 μM)-DNA adducts contain one or two drug molecules bound to double-stranded DNA. PNU-159682 (100 μM) weakly inhibits topoisomerase II unknotting activity [1][2][3]. |
In vivo | PNU-159682 (25 nmol/kg) shows an effective antitumor effect in mice bearing SKRC-52 xenografted tumors. PNU-159682 (15 μg/kg, i.v.) displays antitumor activity in mice bearing disseminated murine L1210 leukemia and in MX-1 human mammary carcinoma xenografts at 4 μg/kg[1][3]. |
Molecular Weight | 641.62 |
Formula | C32H35NO13 |
CAS No. | 202350-68-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 96.7 mg/mL (150.71 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PNU-159682 202350-68-3 DNA Damage/DNA Repair Topoisomerase PNU 159682 inhibit non-Hodgkin’s lymphoma PNU159682 ADCs Toxin acute myeloid leukemia ADC Payload EDV nanocell AML Inhibitor ADC Cytotoxin NMS249 NHL inhibitor